List: First north sweden
Business: Cold medication preventive
Due to a cold shower press release from enzymatica today I have decided to temporarily sell some of my position. Management concludes that the COVID effect has temporarily drastically decreased the cold market in Europe and guidance has been lowered for 2021. New deals appear to be close so I won’t be waiting to long to add. If it drops below 10 SEK or about I will be a buyer. The company also plans to do a capital injection of 60 MSEK for growth purposes.
Long term the investment case remains the same and I still have a firm belief in the company.
I own shares in this company personally and this is not to be considered financial advise, always do your own research!
Don’t forget to subscribe to this blog by pressing “follow” or going to the main page furthest down and sign up to receive news update as soon as they’re published!